Mitchell L. Krassan

2014

In 2014, Mitchell L. Krassan earned a total compensation of $438.5K as Executive Vice President and Chief Strategy Officer at TherapeuticsMD, a 95% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$15,000
Option Awards$197,917
Salary$213,200
Other$12,379
Total$438,496

Krassan received $213.2K in salary, accounting for 49% of the total pay in 2014.

Krassan also received $15K in non-equity incentive plan, $197.9K in option awards and $12.4K in other compensation.

Rankings

In 2014, Mitchell L. Krassan's compensation ranked 10,715th out of 13,032 executives tracked by ExecPay. In other words, Krassan earned more than 17.8% of executives.

ClassificationRankingPercentile
All
10,715
out of 13,032
18th
Division
Manufacturing
4,083
out of 4,966
18th
Major group
Chemicals And Allied Products
1,404
out of 1,686
17th
Industry group
Drugs
1,125
out of 1,365
18th
Industry
Pharmaceutical Preparations
858
out of 1,043
18th
Source: SEC filing on April 25, 2017.

Krassan's colleagues

We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2014.

2014

Robert Finizio

TherapeuticsMD

Chief Executive Officer

2014

John Milligan

TherapeuticsMD

Secretary

2014

Daniel Cartwright

TherapeuticsMD

Chief Financial Officer

2014

Michael Donegan

TherapeuticsMD

Vice President - Finance

News

You may also like